GILD vs WEAV · P/E 18, rev $7.80B vs rev $133.0M
Gilead Sciences Inc (GILD) versus Weave Communications Inc (WEAV) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Weave Communications Inc (WEAV) is a health information services company listed on NYSE.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported WEAV revenue for 2026-06-30 was $133.0M. Net income was -$10.0M. WEAV currently screens at market cap $440.0M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. WEAV currently screens at market cap $440.0M.
Not investment advice. Open the GILD and WEAV stock pages for the full models.
Not investment advice.